UKMi Q&A via SPS – New Resources

UKMi publish a series of Q&A documents on the NHS SPS website, with summaries of high quality, evidence-based, and quality controlled […]

Aldosterone Antagonist Monitoring: Room for Improvement in UK Primary Care

NICE recommend offering or considering the addition of an aldosterone antagonist (AA), such as spironolactone and eplerenone, to treatment with an angiotensin-converting […]

Emollients: risk of severe and fatal burns

The MHRA have issued new warnings about fire & burns risk with emollients. The new warnings state that ALL emollients may […]

Consultation events on items which should not routinely be prescribed in primary care

As part of our latest consultation on items which should not routinely be prescribed in primary care the following events […]

Flash glucose monitoring

NHS England recently announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, […]

Antibiotic Allergy – Mislabelling Contributes to Resistance

The Lancet has published a global update on antibiotic allergy epidemiology, classification, mechanisms, and management – highlighting the public health importance […]

COPD – New NICE Guidance

NICE has published updated guidance on Diagnosis & Management of COPD, with new recommendations on: incidental findings on chest X‑rays […]

Problematic Polypharmacy – Health Secretary Initiative

The Secretary of State for Health & Social Care, Matt Hancock, has asked the Chief Pharmaceutical Officer, Keith Ridge, to […]

Adalat – Supply Issues

Bayer have announced plans to permanently discontinue nifedipine immediate-release 5mg & 10mg capsules (Adalat) in 2019. There are no other […]